Meyer L - Search Results

1

Differences in HIV natural history among African and non-African seroconverters in Europe and seroconverters in sub-Saharan Africa.

Pantazis N, Morrison C, Amornkul PN, Lewden C, Salata RA, Minga A, Chipato T, Jaffe H, Lakhi S, Karita E, Porter K, Meyer L, Touloumi G; CASCADE Collaboration in EuroCoord and ANRS 1220 Primo-CI Study Group. Pantazis N, et al. Among authors: meyer l. PLoS One. 2012;7(3):e32369. doi: 10.1371/journal.pone.0032369. Epub 2012 Mar 6. PLoS One. 2012. PMID: 22412867 Free PMC article.

2

The use of auxiliary events to improve the analysis of survival for HIV-infected patients: application to the French Prospective Multicenter Cohort (SEROCO).

Flandre P, Boufassa F, Gerard L, Carré N, Persoz A, Meyer L. Flandre P, et al. Among authors: meyer l. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jun 1;12(2):174-81. doi: 10.1097/00042560-199606010-00011. J Acquir Immune Defic Syndr Hum Retrovirol. 1996. PMID: 8680889

3

High risk of HIV disease progression after infection through a sexual partner with AIDS.

Carré N, Meyer L, Boufassa F, Deveau C, Persoz A, Rouzioux C, Vildé JL. Carré N, et al. Among authors: meyer l. AIDS. 1996 Jan;10(1):77-80. doi: 10.1097/00002030-199601000-00011. AIDS. 1996. PMID: 8924255

4

HEMOCO: a French prospective study of hemophiliacs infected by human immunodeficiency virus type 1 (HIV-1).

Boufassa F, Carré N, Deveau C, Sultan Y, Gazengel C, Blanc A, Peynet J, Ramirez D, Meyer L. Boufassa F, et al. Among authors: meyer l. Hematol Cell Ther. 1996 Apr;38(2):193-8. doi: 10.1007/s00282-996-0193-7. Hematol Cell Ther. 1996. PMID: 8932002

5

Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load. The SEROCO Study Group.

Meyer L, Magierowska M, Hubert JB, Rouzioux C, Deveau C, Sanson F, Debre P, Delfraissy JF, Theodorou I. Meyer L, et al. AIDS. 1997 Sep;11(11):F73-8. doi: 10.1097/00002030-199711000-00001. AIDS. 1997. PMID: 9302436

6

Has the rate of progression to AIDS changed in recent years?

Carré N, Prins M, Meyer L, Brettle RP, Robertson JR, McArdle H, Goldberg DJ, Zangerle R, Coutinho RA, van den Hoek A. Carré N, et al. Among authors: meyer l. AIDS. 1997 Nov;11(13):1611-8. doi: 10.1097/00002030-199713000-00010. AIDS. 1997. PMID: 9365766

7

Influence of age at infection on human immunodeficiency virus disease progression to different clinical endpoints: the SEROCO cohort (1988-1994). The Seroco Study Group.

Belanger F, Meyer L, Carré N, Coutellier A, Deveau C. Belanger F, et al. Among authors: meyer l. Int J Epidemiol. 1997 Dec;26(6):1340-5. doi: 10.1093/ije/26.6.1340. Int J Epidemiol. 1997. PMID: 9447415

8

Predictive value of viral load and other markers for progression to clinical AIDS after CD4+ cell count falls below 200/microL. SEROCO & HEMOCO Study Group.

Carré N, Boufassa F, Hubert JB, Chavance M, Rouzioux C, Goujard C, Laurian Y, Meyer L. Carré N, et al. Among authors: meyer l. Int J Epidemiol. 1998 Oct;27(5):897-903. doi: 10.1093/ije/27.5.897. Int J Epidemiol. 1998. PMID: 9839750

9

[Primary HIV-1 infection].

Meyer L, Goujard C. Meyer L, et al. Rev Prat. 1999 Oct 15;49(16):1750-5. Rev Prat. 1999. PMID: 10578605 French.

10

Natural history of serum HIV-1 RNA levels in 330 patients with a known date of infection. The SEROCO Study Group.

Hubert JB, Burgard M, Dussaix E, Tamalet C, Deveau C, Le Chenadec J, Chaix ML, Marchadier E, Vildé JL, Delfraissy JF, Meyer L, Rouzioux. Hubert JB, et al. Among authors: meyer l. AIDS. 2000 Jan 28;14(2):123-31. doi: 10.1097/00002030-200001280-00007. AIDS. 2000. PMID: 10708282

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,314 results

Search Page

Filters